vs

Side-by-side financial comparison of GERON CORP (GERN) and MFA FINANCIAL, INC. (MFA). Click either name above to swap in a different company.

MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $47.2M, roughly 1.2× GERON CORP). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 9.2%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 7.7%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.

GERN vs MFA — Head-to-Head

Bigger by revenue
MFA
MFA
1.2× larger
MFA
$55.5M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+57.8% gap
GERN
67.1%
9.2%
MFA
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
7.7%
MFA

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
MFA
MFA
Revenue
$47.2M
$55.5M
Net Profit
$-18.4M
Gross Margin
Operating Margin
-29.4%
97.9%
Net Margin
-39.0%
Revenue YoY
67.1%
9.2%
Net Profit YoY
30.3%
EPS (diluted)
$-0.03
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
MFA
MFA
Q4 25
$55.5M
Q3 25
$47.2M
$56.8M
Q2 25
$49.0M
$61.3M
Q1 25
$39.6M
$57.5M
Q4 24
$50.8M
Q3 24
$28.3M
$50.6M
Q2 24
$882.0K
$53.5M
Q1 24
$304.0K
$47.8M
Net Profit
GERN
GERN
MFA
MFA
Q4 25
Q3 25
$-18.4M
$48.1M
Q2 25
$-16.4M
$33.2M
Q1 25
$-19.8M
$41.2M
Q4 24
Q3 24
$-26.4M
$48.2M
Q2 24
$-67.4M
$41.9M
Q1 24
$-55.4M
$23.2M
Operating Margin
GERN
GERN
MFA
MFA
Q4 25
97.9%
Q3 25
-29.4%
84.5%
Q2 25
-25.4%
54.5%
Q1 25
-42.2%
70.0%
Q4 24
6.8%
Q3 24
-99.8%
98.2%
Q2 24
-7860.9%
79.1%
Q1 24
-18465.1%
50.7%
Net Margin
GERN
GERN
MFA
MFA
Q4 25
Q3 25
-39.0%
84.7%
Q2 25
-33.4%
54.2%
Q1 25
-50.1%
71.6%
Q4 24
Q3 24
-93.5%
95.2%
Q2 24
-7639.8%
78.4%
Q1 24
-18220.4%
48.5%
EPS (diluted)
GERN
GERN
MFA
MFA
Q4 25
$0.43
Q3 25
$-0.03
$0.35
Q2 25
$-0.02
$0.21
Q1 25
$-0.03
$0.31
Q4 24
$-0.01
Q3 24
$-0.04
$0.37
Q2 24
$-0.10
$0.32
Q1 24
$-0.09
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
MFA
MFA
Cash + ST InvestmentsLiquidity on hand
$78.1M
$213.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$1.8B
Total Assets
$567.4M
$13.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
MFA
MFA
Q4 25
$213.2M
Q3 25
$78.1M
$305.2M
Q2 25
$77.7M
$275.7M
Q1 25
$83.7M
$253.7M
Q4 24
$338.9M
Q3 24
$60.3M
$305.6M
Q2 24
$116.9M
$289.4M
Q1 24
$189.8M
$306.3M
Stockholders' Equity
GERN
GERN
MFA
MFA
Q4 25
$1.8B
Q3 25
$248.7M
$1.8B
Q2 25
$259.5M
$1.8B
Q1 25
$268.2M
$1.8B
Q4 24
$1.8B
Q3 24
$292.3M
$1.9B
Q2 24
$306.7M
$1.9B
Q1 24
$344.9M
$1.9B
Total Assets
GERN
GERN
MFA
MFA
Q4 25
$13.0B
Q3 25
$567.4M
$12.1B
Q2 25
$555.2M
$11.7B
Q1 25
$562.5M
$11.5B
Q4 24
$11.4B
Q3 24
$444.9M
$11.2B
Q2 24
$449.4M
$11.1B
Q1 24
$482.1M
$10.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
MFA
MFA
Operating Cash FlowLast quarter
$-13.6M
$76.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
MFA
MFA
Q4 25
$76.2M
Q3 25
$-13.6M
$14.7M
Q2 25
$-27.4M
$38.5M
Q1 25
$-48.0M
$-14.6M
Q4 24
$200.1M
Q3 24
$-58.9M
$-11.3M
Q2 24
$-53.5M
$46.5M
Q1 24
$-62.3M
$53.5M
Free Cash Flow
GERN
GERN
MFA
MFA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
GERN
GERN
MFA
MFA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
GERN
GERN
MFA
MFA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
GERN
GERN
MFA
MFA
Q4 25
Q3 25
0.31×
Q2 25
1.16×
Q1 25
-0.35×
Q4 24
Q3 24
-0.23×
Q2 24
1.11×
Q1 24
2.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons